The results of the Phase I/II trial published in the scientific journal, The Lancet, indicate no early safety concerns and induces strong immune responses in both parts of the immune system.
source https://www.pharmatutor.org/pharma-news/2020/oxford-covid-19-vaccine-produces-strong-immune-response
No comments:
Post a Comment